Mechanism of Action and Biological Profile of HMG CoA Reductase Inhibitors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 • 5,638 citations
The Lipid Research Clinics Coronary Primary Prevention Trial Results
1984 • 2,673 citations
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
1980 • 1,607 citations
ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
1976 • 926 citations
Lipid Research Clinics Program
1984 • 837 citations
Regulation of HMG-CoA Reductase
1976 • 743 citations
The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
1984 • 631 citations
Familial Hypercholesterolemia: Identification of a Defect in the Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity Associated with Overproduction of Cholesterol
1973 • 442 citations
CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
1986 • 376 citations
Efficacy and long-term adverse effect pattern of lovastatin
1988 • 338 citations
Lipid metabolism and atherosclerosis
1951 • 298 citations
β-hydroxy-β-methylglutaryl coenzyme a reductase, cleavage and condensing enzymes in relation to cholesterol formation in rat liver
1960 • 289 citations
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side-chain ester derivatives of mevinolin
1986 • 261 citations
Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor.
1979 • 186 citations
Detection of Familial Hypercholesterolemia by Assaying Functional Low-Density-Lipoprotein Receptors on Lymphocytes
1986 • 109 citations
Hydroxymethylglutaryl-coenzyme A reductase-containing hepatocytes are distributed periportally in normal and mevinolin-treated rat livers.
1984 • 99 citations
Ultrastructural analysis of crystalloid endoplasmic reticulum in ut-1 cells and its disappearance in response to cholesterol
1983 • 95 citations
Regulation of hepatic receptor-dependent degradation of LDL by mevinolin in rabbits with hypercholesterolemia induced by a wheat starch-casein diet
1983 • 56 citations
Lovastatin, an inhibitor of cholesterol synthesis, induces hydroxymethylglutaryl-coenzyme A reductase directly on membranes of expanded smooth endoplasmic reticulum in rat hepatocytes.
1988 • 56 citations
Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
1988 • 44 citations
Structure elucidation of the bioactive metabolites of ML-236B (mevastatin) isolated from dog urine.
1986 • 35 citations
[Lipid metabolism and atherosclerosis].
1963 • 22 citations
Hydroxymethylglutaryl-coenzyme A reductase exhibits graded distribution in normal and mevinolin-treated ileum.
1987 • 12 citations
3-Hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors: A New Class of Cholesterol-Lowering Agents
1987 • 10 citations